Semaglutide and Vision Problems: What the Latest Research Reveals

Aug 26, 2025

Could a popular diabetes and weight-loss drug affect your vision? A new 2025 study in BMC Medicine examined whether semaglutide—sold under the names Ozempic, Wegovy, and Rybelsus—is associated with vision problems like optic nerve damage and diabetic retinopathy. Researchers analyzed over 300,000 FDA safety reports to look for patterns that could impact patients already at risk.

Reported by

Reviewed by

You May Also Like